Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
KAAAAAAAAAAAAAAABOOOOOOOOOOOOOOOOOOOOM
strong buy ,,FDA Decision on the way
PDUFA date on November 30, could hit 6$ before --> STRONG BUY AGRESSIVE
great buying opp aheadof the FDA decision
$20 stock trading at laughable $3.50
Aquestive backs FY19 revenue $38M-$45M, consensus $42.82M Aquestive Therapeutics announced, in response to Indivior PLC's press release issued earlier today of Indivior's intent to cease production of its authorized generic buprenorphine-naloxone film product, that the company is reaffirming its full year 2019 total revenue guidance. Full year 2019 total revenue is now expected to be at the top end of the company's guidance range of $38M-$45M. Full year 2019 revenue from the company's Suboxone franchise is expected to be at the top end of its guidance range of $29M-$32M. As of October 2019, Suboxone and the authorized generic buprenorphine-naloxone film continue to retain approximately 75% of the market for film treatments of opioid dependence, of which a substantial majority of its retained market share is branded Suboxone.
Read more at:
https://thefly.com/landingPageNews.php?id=2975849
load up guys this is the HOTTEST FDA GEM for this Quarter
pdufa date next month
lots ofupcoming milestones
cheap stock
the pipeline looks good for this company --and the anaylysts seem to like it --strong buy rating.
I bought in a little high stopped loss it out now back in at 3.12
I'm all done with this big dilutive terd for a stock. The selling is just relentless here. Just dumping shares like it's a penny stock scam
Looks like the selling finally dried up. Bring on the bounce AQST
Wonder if we're going to see the same dumping shares at the end of the day today like they did yesterday
AQST $34.00 price target is gonna be awesome from here.
Did anyone notice the JV type deal mentioned in Fridays press release.
https://ih.advfn.com/p.php?pid=nmona&article=78712321
We anticipate partnering tadalafil OF once approved and the CRL has not changed our timing or intent."
Wow look at the Form Ts at $15.15 and a close at $15.19 not $16.86 https://ih.advfn.com/stock-market/NASDAQ/aquestive-therapeutics-inc-mm-AQST/trades
Looks like we're in a downtrend along with the market for now
AQST thin thin thin. Bring on the $20s
AQST so thin back to $18.00 Ameritrade level ll shows there only 600 shares to get there.
Hope the Dow bounces back up today. Closing down over 600 points yesterday was rough on a lot of stocks
Bring on the bounce AQST. Bust that $18.50 area and get to the $20.00s
Aquestive Therapeutics hiring over 20 positions. From $46,000 - $150,000 a year https://www.simplyhired.com/search?q=company%3A%28aquestive%29&job=D_mLxVDBMSGUuKMmcaw8G1WmYVWQtxEkI0GymO6FFqO6SVX1EyX9AA
8-K Nov/8/2018 NEW FDA APPROVAL
https://ih.advfn.com/p.php?pid=nmona&article=78627686
Item 8.01
Other Events.
On November 2, 2018, the Company announced the FDA’sapproval of Sympazan® (clobazam) Oral Film (OF) for the treatment of for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients 2 years of age or older.
AQST$18.51 break and it's off to the races baby
AQST $34.00 PRICE TARGET FROM WEDBUSH
https://www.smarteranalyst.com/brief/wedbush-thinks-aquestive-therapeutics-incs-stock-is-going-to-recover/
Wedbush analyst Liana Moussatos reiterated a Buy rating on Aquestive Therapeutics Inc (NASDAQ: AQST) today and set a price target of $34.
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
198
|
Created
|
11/07/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |